{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:29:49Z","timestamp":1793788189119,"version":"4.6.1"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7212195"],"award-info":[{"award-number":["7212195"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U23A20504"],"award-info":[{"award-number":["U23A20504"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174296"],"award-info":[{"award-number":["82174296"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82004328"],"award-info":[{"award-number":["82004328"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374224"],"award-info":[{"award-number":["82374224"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973627"],"award-info":[{"award-number":["81973627"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.biopha.2024.116405","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T20:12:58Z","timestamp":1710360778000},"page":"116405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Tangshen formula targets the gut microbiota to treat non-alcoholic fatty liver disease in HFD mice: A 16S rRNA and non-targeted metabolomics analyses"],"prefix":"10.1016","volume":"173","author":[{"given":"Shaopeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhou","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.116405_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2021.108602","article-title":"Tomatidine ameliorates obesity-induced nonalcoholic fatty liver disease in mice","volume":"91","author":"Wu","year":"2021","journal-title":"J. Nutr. Biochem."},{"issue":"4","key":"10.1016\/j.biopha.2024.116405_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040837","article-title":"Role and Mechanisms of Mitophagy in Liver Diseases","volume":"9","author":"Ma","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.biopha.2024.116405_bib3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1055\/a-1862-9088","article-title":"Nonalcoholic Fatty Liver Disease: Current Global Burden","volume":"42","author":"El-Kassas","year":"2022","journal-title":"Semin.\u00a0Liver Dis."},{"issue":"12","key":"10.1016\/j.biopha.2024.116405_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2021.12.002","article-title":"Global NAFLD prevalence: a systematic review and meta-analysis","volume":"20","author":"Le","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116405_bib5","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"issue":"16","key":"10.1016\/j.biopha.2024.116405_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/cells11162511","article-title":"Endothelial cell dysfunction and nonalcoholic fatty liver disease (NAFLD): a concise review","volume":"11","author":"Nasiri-Ansari","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2024.116405_bib7","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3389\/fphar.2018.01566","article-title":"Potential nexus of non-alcoholic fatty liver disease and type 2 diabetes mellitus: insulin resistance between hepatic and peripheral tissues","volume":"9","author":"Mu","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"10290","key":"10.1016\/j.biopha.2024.116405_bib8","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.biopha.2024.116405_bib9","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/apt.16575","article-title":"Review article: non-alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations","volume":"54","author":"Polyzos","year":"2021","journal-title":"Aliment Pharm. Ther."},{"issue":"10","key":"10.1016\/j.biopha.2024.116405_bib10","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.clnu.2022.08.001","article-title":"Statins' efficacy in non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"41","author":"Boutari","year":"2022","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.biopha.2024.116405_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.phrs.2020.105298","article-title":"Ugonin J improves metabolic disorder and ameliorates nonalcoholic fatty liver disease by regulating the AMPK\/AKT signaling pathway","volume":"163","author":"Chang","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"20","key":"10.1016\/j.biopha.2024.116405_bib12","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.jacc.2016.02.071","article-title":"Statin-Associated Side Effects","volume":"67","author":"Thompson","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116405_bib13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","article-title":"Current and future pharmacological therapies for NAFLD\/NASH","volume":"53","author":"Sumida","year":"2018","journal-title":"J. Gastroenterol."},{"issue":"19","key":"10.1016\/j.biopha.2024.116405_bib14","article-title":"Xuefu Zhuyu decoction for nonalcoholic fatty liver disease: A protocol for systematic review and meta-analysis","volume":"100","author":"Liu","year":"2021","journal-title":"Med. (Baltim. )."},{"key":"10.1016\/j.biopha.2024.116405_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jep.2023.116927","article-title":"Chinese herbal medicines: The modulator of nonalcoholic fatty liver disease targeting oxidative stress","volume":"318","author":"Gong","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116405_bib16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13020-021-00470-x","article-title":"Herbal therapy for ameliorating nonalcoholic fatty liver disease via rebuilding the intestinal microecology","volume":"16","author":"Yang","year":"2021","journal-title":"Chin. Med."},{"issue":"3","key":"10.1016\/j.biopha.2024.116405_bib17","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.3390\/nu13031037","article-title":"Soluble Fiber Inulin Consumption Limits Alterations of the Gut Microbiota and Hepatic Fatty Acid Metabolism Caused by High-Fat Diet","volume":"13","author":"Albouery","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2024.116405_bib18","first-page":"17","article-title":"The Role of Gut Microbiota in Some Liver Diseases: From an Immunological Perspective","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.116405_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408398.2023.2212817","article-title":"Potential use of seaweed polysaccharides as prebiotics for management of metabolic syndrome: a review","author":"Wang","year":"2023","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.biopha.2024.116405_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.carbpol.2022.119626","article-title":"The polysaccharides from the fruits of Lycium barbarum L. confer anti-diabetic effect by regulating gut microbiota and intestinal barrier","volume":"291","author":"Zhou","year":"2022","journal-title":"Carbohydr. Polym."},{"issue":"11","key":"10.1016\/j.biopha.2024.116405_bib21","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","article-title":"The gut\u2013liver axis and gut microbiota in health and liver disease","volume":"21","author":"Hsu","year":"2023","journal-title":"Nat. Rev. Microbiol"},{"issue":"6","key":"10.1016\/j.biopha.2024.116405_bib22","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3748\/wjg.v21.i6.1691","article-title":"Gut microbiota and liver diseases","volume":"21","author":"Minemura","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2024.116405_bib23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.phrs.2021.105517","article-title":"Current innovations in nutraceuticals and functional foods for intervention of non-alcoholic fatty liver disease","volume":"166","author":"Zhao","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.biopha.2024.116405_bib24","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3892\/ijmm.2016.2799","article-title":"Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db\/db mice","volume":"38","author":"Kong","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biopha.2024.116405_bib25","first-page":"14","article-title":"Tangshen Formula Alleviates Hepatic Steatosis by Inducing Autophagy Through the AMPK\/SIRT1 Pathway","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2024.116405_bib26","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3634974","article-title":"Protective Role of Tangshen Formula on the Progression of Renal Damage in db\/db Mice by TRPC6\/Talin1 Pathway in Podocytes","volume":"2020","author":"Wang","year":"2020","journal-title":"J. Diabetes Res."},{"issue":"9","key":"10.1016\/j.biopha.2024.116405_bib27","doi-asserted-by":"crossref","first-page":"12053","DOI":"10.1096\/fj.201903102RR","article-title":"Neohesperidin attenuates obesity by altering the composition of the gut microbiota in high-fat diet-fed mice","volume":"34","author":"Lu","year":"2020","journal-title":"Faseb J."},{"key":"10.1016\/j.biopha.2024.116405_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ncomms8489","article-title":"Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota","volume":"6","author":"Chang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2024.116405_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105940","article-title":"\u03bb-carrageenan exacerbates Citrobacter rodentium-induced infectious colitis in mice by targeting gut microbiota and intestinal barrier integrity","volume":"174","author":"Wu","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.biopha.2024.116405_bib30","first-page":"20","article-title":"Structural Characterization and Anti-Nonalcoholic Fatty Liver Effect of High-Sulfated Ulva pertusa Polysaccharide","volume":"16","author":"Wan","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"12","key":"10.1016\/j.biopha.2024.116405_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/foods10123022","article-title":"The Regulatory effects of citrus peel powder on liver metabolites and gut flora in mice with non-alcoholic fatty liver disease (NAFLD)","volume":"10","author":"Hu","year":"2021","journal-title":"Foods"},{"issue":"7","key":"10.1016\/j.biopha.2024.116405_bib32","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3390\/cells12071025","article-title":"Autophagy inhibitor chloroquine downmodulates hepatic stellate cell activation and liver damage in bile-duct-ligated mice","volume":"12","author":"Le","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2024.116405_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106786","article-title":"Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)","volume":"192","author":"Qiu","year":"2023","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2024.116405_bib34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.phrs.2020.104984","article-title":"Molecular mechanisms of hepatic insulin resistance in nonalcoholic fatty liver disease and potential treatment strategies","volume":"159","author":"Zhang","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.biopha.2024.116405_bib35","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1631\/jzus.2006.B0627","article-title":"Research on the protection effect of pioglitazone for non-alcoholic fatty liver disease (NAFLD) in rats","volume":"7","author":"Xu","year":"2006","journal-title":"J. Zhejiang Univ. Sci. B."},{"issue":"1","key":"10.1016\/j.biopha.2024.116405_bib36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12072-020-10121-2","article-title":"How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?","volume":"15","author":"Geng","year":"2021","journal-title":"Hepatol. Int."},{"issue":"11","key":"10.1016\/j.biopha.2024.116405_bib37","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1111\/1750-3841.15929","article-title":"Heukcha, naturally post-fermented green tea extract, ameliorates diet-induced hypercholesterolemia and NAFLD in hamster","volume":"86","author":"Kang","year":"2021","journal-title":"J. Food Sci."},{"issue":"10","key":"10.1016\/j.biopha.2024.116405_bib38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/md20100609","article-title":"Krill Oil Inhibits Cholesterol Synthesis and Stimulated Cholesterol Excretion in Hypercholesterolemic Rats","volume":"20","author":"Kim","year":"2022","journal-title":"Mar. Drugs"},{"issue":"12","key":"10.1016\/j.biopha.2024.116405_bib39","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.2174\/1389450116666150408103318","article-title":"Identification of Lipid Species Linked to the Progression of Non-Alcoholic Fatty Liver Disease","volume":"16","author":"Kawano","year":"2015","journal-title":"Curr. Drug Targets"},{"issue":"24","key":"10.1016\/j.biopha.2024.116405_bib40","first-page":"4","article-title":"The AST\/ALT (De-Ritis) ratio A novel marker for critical limb ischemia in peripheral arterial occlusive disease patients","volume":"95","author":"Rief","year":"2016","journal-title":"Med. (Baltim. )."},{"issue":"1","key":"10.1016\/j.biopha.2024.116405_bib41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41467-023-36776-7","article-title":"Molecular imaging of liver inflammation using an anti-VCAM-1 nanobody","volume":"14","author":"Nachit","year":"2023","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2024.116405_bib42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/ijms23020662","article-title":"The Intestinal Barrier and Its Dysfunction in Patients with Metabolic Diseases and Non-Alcoholic Fatty Liver Disease","volume":"23","author":"Forlano","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.biopha.2024.116405_bib43","doi-asserted-by":"crossref","first-page":"7287","DOI":"10.1039\/D2FO01009G","article-title":"Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats","volume":"13","author":"Zhong","year":"2022","journal-title":"Food Funct."},{"key":"10.1016\/j.biopha.2024.116405_bib44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.phrs.2021.106020","article-title":"Lactobacillus acidophilus ameliorates obesity in mice through modulation of gut microbiota dysbiosis and intestinal permeability","volume":"175","author":"Kang","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"68","key":"10.1016\/j.biopha.2024.116405_bib45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1126\/sciimmunol.abk2092","article-title":"Epithelial Gasdermin D shapes the host-microbial interface by driving mucus layer formation","volume":"7","author":"Zhang","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.biopha.2024.116405_bib46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.phrs.2021.105781","article-title":"Protective effect of isosteviol sodium against LPS-induced multiple organ injury by regulating of glycerophospholipid metabolism and reducing macrophage-driven inflammation","volume":"172","author":"Wang","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2024.116405_bib47","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fnut.2021.700058","article-title":"Role of the Gut Microbiota in Regulating Non-alcoholic Fatty Liver Disease in Children and Adolescents","volume":"8","author":"Tokuhara","year":"2021","journal-title":"Front. Nutr."},{"issue":"3","key":"10.1016\/j.biopha.2024.116405_bib48","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/pca.3098","article-title":"UPLC-MS\/MS method for the determination of the herb composition of Tangshen formula and the in vivo pharmacokinetics of its metabolites in rat plasma","volume":"33","author":"Yao","year":"2022","journal-title":"Phytochem. Anal."},{"issue":"1","key":"10.1016\/j.biopha.2024.116405_bib49","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/14786419.2016.1207070","article-title":"Unusual alkaloids of the highland species Astragalus cryptanthus Wedd. (Fabaceae)","volume":"31","author":"Echeverr\u00eda","year":"2017","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.biopha.2024.116405_bib50","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.nut.2018.10.002","article-title":"Probiotics improve gut microbiota dysbiosis in obese mice fed a high fat or high-sucrose diet","volume":"60","author":"Kong","year":"2019","journal-title":"Nutrition"},{"key":"10.1016\/j.biopha.2024.116405_bib51","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.nutres.2021.04.008","article-title":"A rise in Proteobacteria is an indicator of gut-liver axis-mediated nonalcoholic fatty liver disease in high-fructose-fed adult mice","volume":"91","author":"Vasques-Monteiro","year":"2021","journal-title":"Nutr. Res."},{"issue":"18","key":"10.1016\/j.biopha.2024.116405_bib52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/ijms231810980","article-title":"Bile Salt Hydrolases with Extended Substrate Specificity Confer a High Level of Resistance to Bile Toxicity on Atopobiaceae Bacteria","volume":"23","author":"Morinaga","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116405_bib53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.phrs.2020.104942","article-title":"Bletilla striata oligosaccharides improve metabolic syndrome through modulation of gut microbiota and intestinal metabolites in high fat diet-fed mice","volume":"159","author":"Hu","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.biopha.2024.116405_bib54","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.fshw.2022.04.023","article-title":"Alteration of fecal microbiome and metabolome by mung bean coat improves diet-induced non-alcoholic fatty liver disease in mice","volume":"11","author":"Hou","year":"2022","journal-title":"Food Sci. Hum. Wellness"},{"issue":"4","key":"10.1016\/j.biopha.2024.116405_bib55","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1016\/j.clnme.2013.05.001","article-title":"Assessment of efficacy of a potential probiotic strain and its antiuremic and antioxidative activities","volume":"8","author":"Mandal","year":"2013","journal-title":"E-SPEN J."},{"issue":"5","key":"10.1016\/j.biopha.2024.116405_bib56","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1099\/ijsem.0.002735","article-title":"Ellagibacter isourolithinifaciens gen. nov., sp nov., a new member of the family Eggerthellaceae, isolated from human gut","volume":"68","author":"Beltr\u00e1n","year":"2018","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"10.1016\/j.biopha.2024.116405_bib57","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fmicb.2017.01521","article-title":"Isolation of Human Intestinal Bacteria Capable of Producing the Bioactive Metabolite Isourolithin A from Ellagic Acid","volume":"8","author":"Selma","year":"2017","journal-title":"Front. Microbiol."},{"issue":"9","key":"10.1016\/j.biopha.2024.116405_bib58","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/s41430-018-0386-5","article-title":"A pilot study of the effect of phospholipid curcumin on serum metabolomic profile in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial","volume":"73","author":"Chashmniam","year":"2019","journal-title":"Eur. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.biopha.2024.116405_bib59","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3109\/10715762.2010.540574","article-title":"Suppression of mitochondrial NADP(+)-dependent isocitrate dehydrogenase activity enhances curcumin-induced apoptosis in HCT116 cells","volume":"45","author":"Jung","year":"2011","journal-title":"Free Radic. Res."},{"issue":"1","key":"10.1016\/j.biopha.2024.116405_bib60","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/ajcn\/73.1.41","article-title":"Behenic acid is a cholesterol-raising saturated fatty acid in humans","volume":"73","author":"Cater","year":"2001","journal-title":"Am. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.biopha.2024.116405_bib61","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/ijpo.12114","article-title":"Combined untargeted and targeted metabolomic profiling reveals urinary biomarkers for discriminating obese from normal-weight adolescents","volume":"12","author":"Cho","year":"2017","journal-title":"Pediatr. Obes."},{"key":"10.1016\/j.biopha.2024.116405_bib62","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12986-018-0241-7","article-title":"Associations between fatty acid oxidation, hepatic mitochondrial function, and plasma acylcarnitine levels in mice","volume":"15","author":"Bjorndal","year":"2018","journal-title":"Nutr. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2024.116405_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-5793(96)00603-5","article-title":"Palmitoylcarnitine, a surface-active metabolite","volume":"390","author":"Go\u00f1i","year":"1996","journal-title":"FEBS Lett."},{"issue":"5","key":"10.1016\/j.biopha.2024.116405_bib64","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1159\/000343204","article-title":"Childhood Obesity Is Associated with Changes in the Serum Metabolite Profile","volume":"5","author":"Wahl","year":"2012","journal-title":"Obes. Facts."},{"issue":"2","key":"10.1016\/j.biopha.2024.116405_bib65","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00394-014-0698-8","article-title":"Changes in the serum metabolite profile in obese children with weight loss","volume":"54","author":"Reinehr","year":"2015","journal-title":"Eur. J. Nutr."},{"issue":"21","key":"10.1016\/j.biopha.2024.116405_bib66","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.116.022993","article-title":"Glycerophosphocholine metabolites and cardiovascular disease risk factors in adolescents a cohort study","volume":"134","author":"Syme","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2024.116405_bib67","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jff.2021.104496","article-title":"Serum metabonomics revealed the mechanism of Ganoderma amboinense polysaccharides in preventing non-alcoholic fatty liver disease (NAFLD) induced by high-fat diet","volume":"82","author":"Ren","year":"2021","journal-title":"J. Funct. Food"},{"key":"10.1016\/j.biopha.2024.116405_bib68","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jff.2020.104061","article-title":"Caffeic acid reduces body weight by regulating gut microbiota in diet-induced-obese mice","volume":"74","author":"Xu","year":"2020","journal-title":"J. Funct. Food"},{"key":"10.1016\/j.biopha.2024.116405_bib69","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fphar.2021.621339","article-title":"Ferulic acid ameliorates atherosclerotic injury by modulating gut microbiota and lipid metabolism","volume":"12","author":"Gu","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116405_bib70","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3390\/nu12051488","article-title":"Effect of hesperidin on cardiovascular disease risk factors: the role of intestinal microbiota on hesperidin bioavailability","volume":"12","author":"Mas-Capdevila","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2024.116405_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104966","article-title":"Anti-inflammatory effect of luteolin is related to the changes in the gut microbiota and contributes to preventing the progression from simple steatosis to nonalcoholic steatohepatitis","volume":"112","author":"Sun","year":"2021","journal-title":"Bioorg. Chem."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224002890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224002890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:08:06Z","timestamp":1793786886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224002890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":71,"alternative-id":["S0753332224002890"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116405","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tangshen formula targets the gut microbiota to treat non-alcoholic fatty liver disease in HFD mice: A 16S rRNA and non-targeted metabolomics analyses","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116405"}}